BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 11457884)

  • 1. A virus-induced molecular mimicry model of multiple sclerosis.
    Olson JK; Croxford JL; Calenoff MA; Dal Canto MC; Miller SD
    J Clin Invest; 2001 Jul; 108(2):311-8. PubMed ID: 11457884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional activation of myelin-specific T cells by virus-induced molecular mimicry.
    Olson JK; Eagar TN; Miller SD
    J Immunol; 2002 Sep; 169(5):2719-26. PubMed ID: 12193746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A virus-induced molecular mimicry model of multiple sclerosis.
    Olson JK; Ercolini AM; Miller SD
    Curr Top Microbiol Immunol; 2005; 296():39-53. PubMed ID: 16323419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection.
    Miller SD; Olson JK; Croxford JL
    J Autoimmun; 2001 May; 16(3):219-27. PubMed ID: 11334486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus.
    Croxford JL; Ercolini AM; Degutes M; Miller SD
    Eur J Immunol; 2006 Oct; 36(10):2671-80. PubMed ID: 16981179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
    Croxford JL; Anger HA; Miller SD
    J Immunol; 2005 Jan; 174(2):907-17. PubMed ID: 15634913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
    J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry.
    Olson JK; Ludovic Croxford J; Miller SD
    Mol Immunol; 2004 Feb; 40(14-15):1103-8. PubMed ID: 15036915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.
    Miller SD; Vanderlugt CL; Begolka WS; Pao W; Yauch RL; Neville KL; Katz-Levy Y; Carrizosa A; Kim BS
    Nat Med; 1997 Oct; 3(10):1133-6. PubMed ID: 9334726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.
    Croxford JL; Olson JK; Anger HA; Miller SD
    J Virol; 2005 Jul; 79(13):8581-90. PubMed ID: 15956599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice.
    Katz-Levy Y; Neville KL; Padilla J; Rahbe S; Begolka WS; Girvin AM; Olson JK; Vanderlugt CL; Miller SD
    J Immunol; 2000 Nov; 165(9):5304-14. PubMed ID: 11046065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.
    Begolka WS; Haynes LM; Olson JK; Padilla J; Neville KL; Dal Canto M; Palma J; Kim BS; Miller SD
    J Neurovirol; 2001 Oct; 7(5):409-20. PubMed ID: 11582513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL; Dal Canto MC; Bluestone JA; Miller SD
    J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery.
    Ercolini AM; Ludovic Croxford J; Degutes M; Miller SD
    J Neuroimmunol; 2007 May; 186(1-2):5-18. PubMed ID: 17376542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity.
    Dal Canto MC; Calenoff MA; Miller SD; Vanderlugt CL
    J Neuroimmunol; 2000 Apr; 104(1):79-84. PubMed ID: 10683517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms].
    Molina-Holgado E; Areválo-Martín A; Vela JM; Guaza C
    Rev Neurol; 2002 Nov 16-30; 35(10):973-8. PubMed ID: 12436402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS.
    Neville KL; Padilla J; Miller SD
    J Neuroimmunol; 2002 Feb; 123(1-2):18-29. PubMed ID: 11880145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.